Abstract: A polymeric prodrug composition including a hydrogel, a biologically active moiety and a reversible prodrug linker. The prodrug linker covalently links the hydrogel and the biologically active moiety at a position and the hydrogel has a plurality of pores with openings on its surface. The diameter of the pores is larger than that of the biologically active moiety at least at all points of the pore between at least one of the openings and the position of the biologically active moiety.
Type:
Grant
Filed:
October 7, 2004
Date of Patent:
June 28, 2011
Assignee:
Ascendis Pharma A/S
Inventors:
Ulrich Hersel, Harald Rau, Robert Schnepf, Dirk Vetter, Thomas Wegge
Abstract: The application relates to a composition comprising a hyperbranched polymer attached to a core and a biologically active moiety. The biologically active moiety is attached to the core by means of a substantially non-enzymatically cleavable linker L. The composition can be used to deliver the biologically active moiety to its target.
Type:
Grant
Filed:
October 1, 2004
Date of Patent:
February 1, 2011
Assignee:
Ascendis Pharma A/S
Inventors:
Dirk Vetter, Ulrich Hersel, Harald Rau, Robert Schnepf, Thomas Wegge